Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Canagliflozin Added on to Dipeptidyl Peptidase-4 Inhibitors or Glucagon-Like Peptide-1 Agonists With or Without Other Antihyperglycemic Agents in Type 2 Diabetes Mellitus (T2DM) Canagliflozin is an SGLT2 inhibitor which was intended for treatment in diabetic type 2 patients. This analysis was a post hoc design and data was utilized …
Read More »Does ED Mean Diabetes?
Men with diabetes develop ED 10 to 15 years earlier than men without diabetes….
Read More »An Altered Gut Microbiota Can Predict Diabetes
Women with type 2 diabetes have distorted microbiota….
Read More »ADA Wants Firms to Disclose Incretin Data
The collected data could help clarify whether the drugs are contributing to the development of pancreatitis or pancreatic cancer….
Read More »Protein Block May Stop Vascular Damage in Diabetes
A protein called NFAT is connected to diabetes and damage to the heart….
Read More »New Type 1 Diabetes Treatment Reduces Need for Insulin Injections
Patients might only need to inject once or twice a week….
Read More »Skipping Breakfast May Increase Risk of Type 2 Diabetes for Women
Glucose total AUC was greater in the no-breakfast group compared with the breakfast group….
Read More »Red Meat Linked to 48% Increased Diabetes Risk
Large study finds higher consumption increases risk, but experts are at odds with findings….
Read More »Blocking the Production of an Enzyme Can Speed Wound Healing
The enzyme, 11β-HSD1, helps to produce cortisol….
Read More »Cognitive Decline Higher with CVD and Type 2 Diabetes
CVD may be playing a role in cognition problems before it is clinically apparent in patients….
Read More »